Non -profit run by 23andme co -founder gets the court’s approval to purchase the genetic testing company

Anne Wajiki’s attempt to buy 23andme, a genetic test company that she participated in its founding nearly 20 years ago, requested the Green Court.

This means that the TTAM Institute for Non -Purful Research in WoJCICKKI will buy “everything” of 23ndme assets that are based in San Francisco for $ 305 million (about $ 416 million of money). The deal – which is more than three months after submitting 23andme to bankruptcy of Chapter 11 – was appointed to be officially closed in the coming weeks.

“I am pleased because TTAM will be able to build on the 23ndme mission to help people reach and benefit from the human genome,” Wogiki said in a statement on Monday. She later added that “the future of health care belongs to all of us.”

The sale, which was approved by the American bankruptcy judge, Brian C, on Friday, represents the end of a bidding war for a period of months between TTAM and Regeneron Pharmaceuticals- a biotechnology company that previously agreed to purchase most of 23ndme assets for $ 256 million in May. But non -profit wojcicki later topped this offer, and won the last round of bids held last month.

Under the deal, TTAM will get the distinctive “personal genome service” for 23andme provided by the DNA test sets based on saliva-in addition to its LEMONAID searches and its LEMONAID searches, and it is a service provider from a distance from a remote planning for the previous 23ndme to finish.

WoJCICKI’s work to take your 23ndme for some time. With the company struggling to find a profitable business model since it was launched in 2021, it confirmed that it will work better in market pressure. However, this endeavor proved that it is noisy-especially in September last year, when all the directors of independent 23ndme resigned from its board of directors, referring to a “clear” difference in opinion with Wojcicki on the company’s future after the negotiated negotiations.

Before submitting 23ndme bankruptcy in March, the subsequent efforts from Wojcicki did not succeed to obtain the company. When 23ndme applied to Chapter 11 in late March, Wojcikki resigned as an executive president – noting at the time that she was stepped down to be “in the best position” as an independent bidding.

Now that the non -profit WoJCICKI Foundation has gained 23andme, it is not clear whether the co -founder will return to the seat of the CEO. But despite the removal of the highest months after months, wojcicki remained on the company’s board of directors throughout the bankruptcy process.

In addition to the financial breeds leading to the bankruptcy of 23ndme, concerns related to privacy related to the genetic information of customers – whose history dates back even before the bankruptcy process have emerged, especially with data breach 2023. But concern about what the new ownership may mean for the data of 23andme personal users has erupted in recent months.

The court documents indicate that the genetic testing company has about 13 million customers at the time of the sale session.

In June, 27 states and provinces of Colombia filed a lawsuit seeking to prevent the sale of personal genetic data under 23andme without the approval of the customer. In a note that determines his approval to sell 23andme to TTAM on Friday, Walsh admitted that the objections of these states to the acquisition – but this indicated that many have been resolved since then. However, California, Kentucky, Tennessee, Tixas and Utah “are still actively opposed to sale.”

In a statement of policy on Monday, California Prosecutor’s Office, Rob Punta, confirmed that the sale of 23andme “does not comply with” the state’s genetic privacy law – and said that it was “disappointed” with the approval of the court, adding that it was establishing the following steps.

Associated Press arrived at the Punta office for more comments on Tuesday.

When announcing its intended sale to non -profit wojcicki last month, 23andme confirmed that TTAM “confirmed its commitment” to comply with the company’s privacy policies and the applicable law. This means that TTAM will honor the current policies on consumer data, which includes allowing users to delete their data and “cancel the subscription” from the search.

23ndme said that all customers will be sent by e -mail at least two working day before the acquisition closed – with details about TTAM’s special obligations and instructions on how to delete data or cancel the search. The company added that TTAM will provide customers for two years of monitoring the theft of Experian without any cost.

23ndme remedy these privacy policies on Monday. “The essence of my beliefs is that individuals should be enabled from choice and transparency in relation to their genetic data and they have the opportunity to continue to identify their ancestors and their health risks as they like,” said Wojcicki.